12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, health care stocks showed significant movement with Aethlon Medical, Novavax, and Sensus Healthcare leading the gains, while Macrogenics, Progyny, and Protalix BioTherapeutics were among the top losers. The movements were largely driven by the release of Q1 earnings reports.
May 10, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Macrogenics experienced a significant drop of 67.0% to $4.84, with a market cap of $302.7 million, after their Q1 earnings were released.
The sharp decline in MGNX's stock price is likely due to negative investor reaction to their Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Progyny's stock fell 25.54% to $24.2, with a market cap of $2.3 billion, following their Q1 earnings announcement.
The decrease in PGNY's stock price can be attributed to the market's negative reception of their Q1 earnings.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Protalix BioTherapeutics saw a 16.0% decrease to $1.05, with a market cap of $76.9 million, after their Q1 earnings report.
The decline in PLX's stock price is likely due to investor disappointment with their Q1 earnings.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Aethlon Medical's stock soared by 129.0% to $2.7, with a market cap of $7.1 million, indicating strong investor response to recent developments.
The significant surge in AEMD's stock price is likely due to positive investor sentiment surrounding the company's latest developments or financial results.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Novavax shares rose sharply by 119.23% to $9.8, with a market cap of $1.3 billion, following the release of their Q1 earnings.
The dramatic increase in NVAX's stock price can be attributed to the market's positive reaction to their Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100